Form 4 Tracker
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA

64 insider filings · Latest: Jun 18, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 18, 2026Jun 22 8:00 PMMatthew ShieldsEVP, Global Operations
Sale
9,989$32.19$321.5K0(D)

View →

Jun 18, 2026Jun 18 8:14 PMShields Matthew
Proposed Sale
9,989$32.19$321.5K

View →

Jun 11, 2026Jun 16 12:28 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Sale
106,563$34.10$3.6M65,621(D)

View →

Jun 11, 2026Jun 11 8:00 PMKalif Eliyahu Sharon
Proposed Sale
106,563$34.10$3.6M

View →

Jun 5, 2026Jun 8 8:01 PMRichard D FrancisPresident and CEO
Sale
6,153$34.35$211.4K1,177,529(D)

View →

Jun 5, 2026Jun 5 8:00 PMFrancis Richard D
Proposed Sale
6,153$34.35$211.4K

View →

Jun 3, 2026Jun 4 8:00 PMMatthew ShieldsEVP, Global Operations
Sale
16,195$32.87$532.3K9,989(D)

View →

Jun 3, 2026Jun 3 7:59 PMShields Matthew
Proposed Sale
16,195$32.87$532.3K

View →

May 14, 2026May 18 8:02 PMEvan LippmanEVP, Business Development
Sale
41,658$35.58$1.5M44,191(D)

View →

May 14, 2026May 18 8:00 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Sale
153,251$35.61$5.5M172,184(D)

View →

May 14, 2026May 14 8:02 PMLippman Evan
Proposed Sale
41,658$35.58$1.5M

View →

May 14, 2026May 14 7:59 PMKalif Eliyahu Sharon
Proposed Sale
153,251$35.61$5.5M

View →

May 6, 2026May 7 8:03 PMAmir WeissChief Accounting Officer
Sale
10,679$36.00$384.4K20,016(D)

View →

May 5, 2026May 7 8:01 PMRichard DaniellEVP, Europe Commercial
Sale
30,000$35.40$1.1M55,755(D)

View →

May 5, 2026May 5 8:00 PMDaniell Richard
Proposed Sale
30,000$35.40$1.1M

View →

May 1, 2026May 4 8:02 PMMark SabagSee "Remarks"
Sale
144,180$34.99$5.0M80,760(D)

View →

Apr 30, 2026May 4 8:00 PMChristine FoxEVP, U.S. Commercial
Sale
21,258$35.31$750.6K63,647(D)

View →

May 1, 2026May 4 12:12 PMSabag Mark
Proposed Sale
144,180$34.99$5.0M

View →

Apr 30, 2026Apr 30 8:40 PMChristine Fox
Proposed Sale
21,258$35.31$750.6K

View →

Mar 17, 2026Mar 19 8:01 PMMark SabagSee "Remarks"
Sale
62,102$30.14$1.9M224,940(D)

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 8 8:07 PMBARER SOL JDirector
Option Exercise
21,7390(D)

View →

Jun 5, 2026Jun 8 8:06 PMChen LichtensteinDirector
Option Exercise
14,4920(D)

View →

Jun 5, 2026Jun 8 8:06 PMRosemary A CraneDirector
Option Exercise
14,4920(D)

View →

Jun 5, 2026Jun 8 8:05 PMAmir ElsteinDirector
Option Exercise
14,4920(D)

View →

Jun 5, 2026Jun 8 8:04 PMGerald M LiebermanDirector
Option Exercise
14,4920(D)

View →

Jun 5, 2026Jun 8 8:04 PMPerry NisenDirector
Option Exercise
14,4920(D)

View →

Jun 5, 2026Jun 8 8:03 PMRonit Satchi-FainaroDirector
Option Exercise
14,4920(D)

View →

Jun 5, 2026Jun 8 8:03 PMTal Zvi ZaksDirector
Option Exercise
14,4920(D)

View →

Jun 5, 2026Jun 8 8:02 PMRoberto MignoneDirector
Option Exercise
14,4920(D)

View →

Jun 5, 2026Jun 8 8:01 PMRichard D FrancisPresident and CEO
Option Exercise
13,04339,130(D)

View →

Jun 3, 2026Jun 4 8:00 PMMatthew ShieldsEVP, Global Operations
Option Exercise
16,19532,392(D)

View →

May 28, 2026Jun 1 8:16 PMTal Zvi ZaksDirector
Grant/Award
7,2427,242(D)

View →

May 28, 2026Jun 1 8:15 PMRonit Satchi-FainaroDirector
Grant/Award
7,2427,242(D)

View →

May 28, 2026Jun 1 8:13 PMPerry NisenDirector
Grant/Award
7,2427,242(D)

View →

May 28, 2026Jun 1 8:11 PMGerald M LiebermanDirector
Grant/Award
7,2427,242(D)

View →

May 28, 2026Jun 1 8:09 PMAmir ElsteinDirector
Grant/Award
7,2427,242(D)

View →

May 28, 2026Jun 1 8:08 PMRosemary A CraneDirector
Grant/Award
7,2427,242(D)

View →

May 28, 2026Jun 1 8:06 PMChen LichtensteinDirector
Grant/Award
7,2427,242(D)

View →

May 28, 2026Jun 1 8:03 PMBARER SOL JDirector
Grant/Award
10,86310,863(D)

View →

May 28, 2026Jun 1 8:02 PMRoberto MignoneDirector
Grant/Award
7,2427,242(D)

View →

Page 1 of 4

Next →